Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
    • GP-001 Documents and records control
    • GP-002 Quality planning
    • GP-003 Audits
    • GP-004 Vigilance system
    • GP-005 HR and training
    • GP-007 Post-market surveillance
    • GP-009 Sales
      • R-009-001 Implementation plans
        • R-009-001 Iderma 20230301
        • R-009-001 Sermas 20230301
        • R-009-001 Galderma 20230727
        • R-009-001 Boehringer Ingelheim 20240207
        • R-009-001 Ribera Salud 20240708
        • R-009-001 Hospital del Mar 20240709
    • GP-010 Suppliers
    • GP-012 Design, Redesign and Development
    • GP-018 Infrastructure and facilities
    • GP-019 Software validation
    • GP-023 Change control management
    • GP-050 Data Protection
    • GP-051 Security violations
    • GP-052 Data Privacy Impact Assessment (DPIA)
  • TF_Legit.Health_Plus
  • Licenses and accreditations
  • External documentation
  • Procedures
  • Records
  • Records
  • GP-009 Sales
  • R-009-001 Implementation plans
  • R-009-001 Galderma 20230727

R-009-001 Galderma 20230727

  • Governed by GP-009 Sales
  • Comes from template T-009-001 Implementation plan

Contract sign date​

Contract sign date: 2023 07 27 (YYYY MM DD)

Project leads​

TeamNameLast nameLeader ofDescription
Legit.HealthTaigMac CarthyTechnical supportProvide assistance if Galderma experiences technical dificulties
Legit.HealthMenelaosTsapekosProject leaderThe person responsible for the overall success and vision for the project
Legit.HealthSaraRecaldeProject managerThe person managing day-to-day operations
GaldermaPatriciaTortajadaExecutive sponsorThe person responsible for the overall success and vision for the project from Galderma
GaldermaRobertoMestoExecutive sponsorThe person responsible for the overall success and vision for the project from Galderma

Goals​

Goals for the proof of concept​

The customer implements Legit.Health's medical device to achieve the following goal(s):

GoalMetricTarget
Increasing sales of Galderma products in pharmaciesPatients210

Secondary Goals for 1st proof of concept​

The customer implements Legit.Health's medical device to achieve the following goal(s):

GoalMetricTarget
Making pharmacies an ally in bringing care closer to the people.Patients210
Have a positive impact on people by helping to improve their health and adherence to Galderma treatments.Patients210
Galderma provides pharmacies with a tool to enrich their existing advice.Pharmacies5
Supporting pharmacies by providing state-of-the-art technology to increase their upsell and cross-sell.Pharmacies5

Implementation timeline​

To achieve the goals, the parties agree on the following timeline.

1st year timeline​

To achieve the goals, the parties agree on the following timeline.

Signature meaning

The signatures for the approval process of this document can be found in the verified commits at the repository for the QMS. As a reference, the team members who are expected to participate in this document and their roles in the approval process, as defined in Annex I Responsibility Matrix of the GP-001, are:

  • Author: Team members involved
  • Reviewer: JD-003, JD-004
  • Approver: JD-001
Previous
R-009-001 Sermas 20230301
Next
R-009-001 Boehringer Ingelheim 20240207
  • Contract sign date
  • Project leads
  • Goals
    • Goals for the proof of concept
    • Secondary Goals for 1st proof of concept
  • Implementation timeline
  • 1st year timeline
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)